pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-516b-1 |
Genomic Coordinates | chr19: 53736845 - 53736934 |
Synonyms | MIRN516-4, MIRN516B-1, MIRN516B1, MIR516B1 |
Description | Homo sapiens miR-516b-1 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases | |
pre-miRNA | hsa-mir-516b-2 |
Genomic Coordinates | chr19: 53725442 - 53725526 |
Synonyms | MIRN516-3, MIRN516B-2, MIRN516B2, MIR516B2 |
Description | Homo sapiens miR-516b-2 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-516b-3p | ||||||||||||||||||||||||||||||||||||||||||
Sequence | 56| UGCUUCCUUUCAGAGGGU |73 | ||||||||||||||||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||||||||||||||||
Experiments | Array-cloned | ||||||||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | OVOL1 | ||||||||||||||||||||
Synonyms | HOVO1 | ||||||||||||||||||||
Description | ovo like transcriptional repressor 1 | ||||||||||||||||||||
Transcript | NM_004561 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on OVOL1 | |||||||||||||||||||||
3'UTR of OVOL1 (miRNA target sites are highlighted) |
>OVOL1|NM_004561|3'UTR 1 GTGGCTCGAGCCCTGGGGGTGCTCCTGGAAGCCCCAAGAGCATCCAGGATTGCCTCCCAGCTGCCTGGCCAGCCCACCCT 81 CCTGCAACCTCTCACCCGAACACCAGTGATCAGGACTGGAGCCCCCGTGCCTTGGTCTCCCCCCTGGGCACACGTGCTCA 161 CTCAGGCCCAGCAATGACCTCTGCTCATTTTTGCATTTTTGACTTATGGGCCGAGGCTGTTCTGAGCCTGGGAAGATGTA 241 CCTATGTCAAGAGAAGGGATGAGGCCAAGGCTGCCTTCAATTAGAAGCAGCCGCCCACAGAGACAGGCACTGTGTGCCTG 321 GCAGCAGGACTTCCTACCCAGAGGAGGTTCGAGCTAGGATCCCACTGCCCCCGCCTCTCAGCACAGGGCAGGGGCTGCAG 401 GTCCCCAGTGGACATCAGAGTCAAAAGCACTGGCAAAGGGTACCCCTGCAAACAACTGTGGTGGGGGCTGGCAGCAGACC 481 CCCCACCTGGCAGGGCTTCTAATGCTCAGGGTTCTGGAGGGCTCTGTCCTTCCGGCAAGGAGAGGCACACATGTGTGCCC 561 AGCCGTGTGTGTGCGTGTGCTTGTGTGTGTGCACTGCTGTGTGTGTGTGCACGCACAGGAAGCCTTTCCACATATCACCT 641 CATTTCTAAGAAATAAACTACAAGGTGCCAAGAAGGTTTTATTTCCTTTTATTTTTTAAAGATGACAAATGTACAGATGT 721 TAATATATTTTTGGTGCCAATGGCGATGTTTTTAAGAGTGGGATGGAGCTGGCTTTTCTCCATTCCCGTGCGCTTCTATT 801 TATCCTGGACATTTCAAACCTCCTCTGTGCCTTGGCTCTGGGCGGGGGCTGCCCCAACCCACCCCCGTTCTTTGTACGTG 881 CTGAGACAGCCACTAGAAGATCTTCCTCCAGCGGCGCCCTGGACGGCTGCTCCTGCGAACAGCCCATGGCATCTTCTGCT 961 CTTCCCTCCCGGCTCTGCCCTGCACATCCTGTTGAGCCAAGCCCCAGTGACCCGGAGAGCTGGCCTGATGCTGAGAGTGT 1041 GTCCTCCTGGGGCTTTAGGGGGCAGGAAGGTGGGACGAATGACGATGCCCATCCACTACCTGAAGCACTAGGACACTCTT 1121 GCAGGGCCAGGCTGGAAGACCGGCCCTTTTCTTGGTTGAGTCAAAAGCCTTAGCACAGTGGCAAAAAATGGGACAGAATG 1201 ATGACCAGCACCTCAGAAACTTCCAGAGGGAGGAGAGGATTTGATGGCTACCAAATTGTATCTGTTGCCTTTTTTCTGAC 1281 TTTTTCACCTGACCAGGCTGGGGTTTGGAGTGGCTGTGGGGAGACCCGTCCTGGCTGGCTGGCTGGCTCCCTTGCTCCCT 1361 TGCTGCAGCTGGGAAAGGGGTTCTGGGTGTAAAGAGGTGTGCGTCTTGTGGGCCAAAGGGAAAAACAGGCAGGGGTCAGA 1441 GCCAGCCTGCCAGAGGCAAATGCAAAAGAGGTCCCCAGAACACAGCCAGCTGGGCAGCCCCTTAAAGCCAAACCCCACCT 1521 GAAGCAGAACCACTTTGGCCTCCCCTGCCCAAAATGGGTAGTGTCTACACGTCCCCGGGCTCAGGCTCAGGCCCAGCCCT 1601 GGGCTGACCTGAGAGGAAGGCTCCTTCCTGGACTGCCCTCTGAAATGTGTATAGATTGATTCTAAAATCTCTTGTTTCAC 1681 TTGACTTTAGAGTGTCTGGGACGCTGCTGTATTCTGAAAGTCACATAGCACACAGTAATGTTATCTGGAAGCTCTGTTTT 1761 TGTTTACATTTCTGTATCCCTGGGTTGACTGCCAATCCGAGGCCGTCATGAAGCTCTGTGTTGTCTGTTTTATTTTATAA 1841 CCTTCCTCTCAACTATTAAAATTAGAGATCTAATGTTTAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | MCF7 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRR1045082. RNA binding protein: AGO2. Condition:Untreated
... - Farazi TA; Ten Hoeve JJ; Brown M; et al., 2014, Genome biology. |
Article |
- Farazi TA; Ten Hoeve JJ; Brown M; et al. - Genome biology, 2014
BACKGROUND: Various microRNAs (miRNAs) are up- or downregulated in tumors. However, the repression of cognate miRNA targets responsible for the phenotypic effects of this dysregulation in patients remains largely unexplored. To define miRNA targets and associated pathways, together with their relationship to outcome in breast cancer, we integrated patient-paired miRNA-mRNA expression data with a set of validated miRNA targets and pathway inference. RESULTS: To generate a biochemically-validated set of miRNA-binding sites, we performed argonaute-2 photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (AGO2-PAR-CLIP) in MCF7 cells. We then defined putative miRNA-target interactions using a computational model, which ranked and selected additional TargetScan-predicted interactions based on features of our AGO2-PAR-CLIP binding-site data. We subselected modeled interactions according to the abundance of their constituent miRNA and mRNA transcripts in tumors, and we took advantage of the variability of miRNA expression within molecular subtypes to detect miRNA repression. Interestingly, our data suggest that miRNA families control subtype-specific pathways; for example, miR-17, miR-19a, miR-25, and miR-200b show high miRNA regulatory activity in the triple-negative, basal-like subtype, whereas miR-22 and miR-24 do so in the HER2 subtype. An independent dataset validated our findings for miR-17 and miR-25, and showed a correlation between the expression levels of miR-182 targets and overall patient survival. Pathway analysis associated miR-17, miR-19a, and miR-200b with leukocyte transendothelial migration. CONCLUSIONS: We combined PAR-CLIP data with patient expression data to predict regulatory miRNAs, revealing potential therapeutic targets and prognostic markers in breast cancer.
LinkOut: [PMID: 24398324]
|
CLIP-seq Support 1 for dataset SRR1045082 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | MCF7 / Untreated |
Location of target site | ENST00000335987.3 | 3UTR | CCUUUCCACAUAUCACCUCAUUUCUAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 24398324 / SRX388831 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
85 hsa-miR-516b-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT077049 | SMARCE1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1 | 2 | 2 | ||||||||
MIRT155261 | IFNAR2 | interferon alpha and beta receptor subunit 2 | 2 | 4 | ||||||||
MIRT446119 | ASTN1 | astrotactin 1 | 2 | 2 | ||||||||
MIRT447355 | STOM | stomatin | 2 | 2 | ||||||||
MIRT469329 | RGP1 | RGP1 homolog, RAB6A GEF complex partner 1 | 2 | 2 | ||||||||
MIRT470201 | PSAT1 | phosphoserine aminotransferase 1 | 2 | 6 | ||||||||
MIRT475944 | GXYLT1 | glucoside xylosyltransferase 1 | 2 | 4 | ||||||||
MIRT498268 | KIAA1644 | KIAA1644 | 2 | 2 | ||||||||
MIRT501725 | OVOL1 | ovo like transcriptional repressor 1 | 2 | 2 | ||||||||
MIRT522860 | KIAA1551 | KIAA1551 | 2 | 2 | ||||||||
MIRT527900 | B3GALT5 | beta-1,3-galactosyltransferase 5 | 2 | 4 | ||||||||
MIRT528557 | DNAAF3 | dynein axonemal assembly factor 3 | 2 | 2 | ||||||||
MIRT531250 | peptide deformylase, mitochondrial | 2 | 2 | |||||||||
MIRT534410 | SENP1 | SUMO1/sentrin specific peptidase 1 | 2 | 2 | ||||||||
MIRT544656 | MED19 | mediator complex subunit 19 | 2 | 2 | ||||||||
MIRT550681 | YARS | tyrosyl-tRNA synthetase | 2 | 2 | ||||||||
MIRT557208 | HNRNPF | heterogeneous nuclear ribonucleoprotein F | 2 | 4 | ||||||||
MIRT611532 | DDB1 | damage specific DNA binding protein 1 | 2 | 2 | ||||||||
MIRT612087 | TIMM10 | translocase of inner mitochondrial membrane 10 | 2 | 2 | ||||||||
MIRT616535 | PARD6B | par-6 family cell polarity regulator beta | 2 | 4 | ||||||||
MIRT616738 | DCTN5 | dynactin subunit 5 | 2 | 2 | ||||||||
MIRT616754 | SVOP | SV2 related protein | 2 | 4 | ||||||||
MIRT617380 | FAM227A | family with sequence similarity 227 member A | 2 | 2 | ||||||||
MIRT617624 | RAB3IP | RAB3A interacting protein | 2 | 2 | ||||||||
MIRT620778 | MT1A | metallothionein 1A | 2 | 2 | ||||||||
MIRT623172 | NAA50 | N(alpha)-acetyltransferase 50, NatE catalytic subunit | 2 | 2 | ||||||||
MIRT626034 | AREL1 | apoptosis resistant E3 ubiquitin protein ligase 1 | 2 | 2 | ||||||||
MIRT627376 | PRICKLE4 | prickle planar cell polarity protein 4 | 2 | 2 | ||||||||
MIRT630533 | AGO3 | argonaute 3, RISC catalytic component | 2 | 2 | ||||||||
MIRT631686 | NQO2 | N-ribosyldihydronicotinamide:quinone reductase 2 | 2 | 2 | ||||||||
MIRT633896 | FGF10 | fibroblast growth factor 10 | 2 | 2 | ||||||||
MIRT635933 | PLA2G12A | phospholipase A2 group XIIA | 2 | 2 | ||||||||
MIRT636275 | RFFL | ring finger and FYVE like domain containing E3 ubiquitin protein ligase | 2 | 2 | ||||||||
MIRT636285 | RAD51L3-RFFL | RAD51L3-RFFL readthrough | 2 | 2 | ||||||||
MIRT636502 | GDAP1L1 | ganglioside induced differentiation associated protein 1 like 1 | 2 | 2 | ||||||||
MIRT638037 | SHPK | sedoheptulokinase | 2 | 2 | ||||||||
MIRT639162 | LAMTOR3 | late endosomal/lysosomal adaptor, MAPK and MTOR activator 3 | 2 | 2 | ||||||||
MIRT639571 | GORASP1 | golgi reassembly stacking protein 1 | 2 | 2 | ||||||||
MIRT641248 | CENPN | centromere protein N | 2 | 2 | ||||||||
MIRT643650 | MYOCD | myocardin | 2 | 2 | ||||||||
MIRT645490 | TRIM63 | tripartite motif containing 63 | 2 | 2 | ||||||||
MIRT648016 | SLCO4C1 | solute carrier organic anion transporter family member 4C1 | 2 | 2 | ||||||||
MIRT648102 | LRRFIP1 | LRR binding FLII interacting protein 1 | 2 | 2 | ||||||||
MIRT648729 | HIST1H2BD | histone cluster 1 H2B family member d | 2 | 2 | ||||||||
MIRT650177 | LILRA2 | leukocyte immunoglobulin like receptor A2 | 2 | 2 | ||||||||
MIRT652787 | TCEANC2 | transcription elongation factor A N-terminal and central domain containing 2 | 2 | 2 | ||||||||
MIRT653248 | SORD | sorbitol dehydrogenase | 2 | 2 | ||||||||
MIRT654859 | PPM1F | protein phosphatase, Mg2+/Mn2+ dependent 1F | 2 | 2 | ||||||||
MIRT655533 | PAG1 | phosphoprotein membrane anchor with glycosphingolipid microdomains 1 | 2 | 2 | ||||||||
MIRT656390 | MCU | mitochondrial calcium uniporter | 2 | 2 | ||||||||
MIRT656881 | KIF1C | kinesin family member 1C | 2 | 2 | ||||||||
MIRT657083 | JMY | junction mediating and regulatory protein, p53 cofactor | 2 | 2 | ||||||||
MIRT657629 | GPX8 | glutathione peroxidase 8 (putative) | 2 | 2 | ||||||||
MIRT658295 | FAM83F | family with sequence similarity 83 member F | 2 | 2 | ||||||||
MIRT659432 | COL1A1 | collagen type I alpha 1 chain | 2 | 2 | ||||||||
MIRT659791 | CBLB | Cbl proto-oncogene B | 2 | 2 | ||||||||
MIRT660153 | BRCC3 | BRCA1/BRCA2-containing complex subunit 3 | 2 | 2 | ||||||||
MIRT660490 | ARRDC3 | arrestin domain containing 3 | 2 | 2 | ||||||||
MIRT660503 | ARPC2 | actin related protein 2/3 complex subunit 2 | 2 | 2 | ||||||||
MIRT666356 | SIKE1 | suppressor of IKBKE 1 | 2 | 2 | ||||||||
MIRT677774 | FKTN | fukutin | 2 | 2 | ||||||||
MIRT688556 | DCAF16 | DDB1 and CUL4 associated factor 16 | 2 | 2 | ||||||||
MIRT697415 | ZFP91 | ZFP91 zinc finger protein | 2 | 2 | ||||||||
MIRT709468 | KRTAP19-1 | keratin associated protein 19-1 | 2 | 2 | ||||||||
MIRT711154 | WDR82P1 | WD repeat domain 82 pseudogene 1 | 2 | 2 | ||||||||
MIRT711467 | SRD5A1 | steroid 5 alpha-reductase 1 | 2 | 2 | ||||||||
MIRT712515 | ENPP5 | ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative) | 2 | 2 | ||||||||
MIRT712661 | PCTP | phosphatidylcholine transfer protein | 2 | 2 | ||||||||
MIRT713304 | TYRP1 | tyrosinase related protein 1 | 2 | 2 | ||||||||
MIRT714597 | HSPA4L | heat shock protein family A (Hsp70) member 4 like | 2 | 2 | ||||||||
MIRT716603 | MPPED1 | metallophosphoesterase domain containing 1 | 2 | 2 | ||||||||
MIRT717537 | PYGO2 | pygopus family PHD finger 2 | 2 | 2 | ||||||||
MIRT718058 | CYP3A5 | cytochrome P450 family 3 subfamily A member 5 | 2 | 2 | ||||||||
MIRT718539 | PIGQ | phosphatidylinositol glycan anchor biosynthesis class Q | 2 | 2 | ||||||||
MIRT719768 | ZNF236 | zinc finger protein 236 | 2 | 2 | ||||||||
MIRT720162 | PNPO | pyridoxamine 5'-phosphate oxidase | 2 | 2 | ||||||||
MIRT720360 | ZBTB8B | zinc finger and BTB domain containing 8B | 2 | 2 | ||||||||
MIRT721182 | HOPX | HOP homeobox | 2 | 2 | ||||||||
MIRT721278 | RAD54L2 | RAD54 like 2 | 2 | 2 | ||||||||
MIRT721357 | ENTHD1 | ENTH domain containing 1 | 2 | 2 | ||||||||
MIRT721504 | CARHSP1 | calcium regulated heat stable protein 1 | 2 | 2 | ||||||||
MIRT721918 | LINGO2 | leucine rich repeat and Ig domain containing 2 | 2 | 2 | ||||||||
MIRT722278 | LURAP1 | leucine rich adaptor protein 1 | 2 | 2 | ||||||||
MIRT722789 | FUT4 | fucosyltransferase 4 | 2 | 2 | ||||||||
MIRT724390 | ABAT | 4-aminobutyrate aminotransferase | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|